Synthesis of DNA molecules in in vitro enzymatic systems

US12371725B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12371725-B2
Application numberUS-202318494425-A
CountryUS
Kind codeB2
Filing dateOct 25, 2023
Priority dateOct 25, 2022
Publication dateJul 29, 2025
Grant dateJul 29, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method, which synthesizes closed circular single-stranded and double-stranded DNA molecules using in vitro enzymatic systems, is described. Circular single-stranded DNA molecules and double-stranded DNA molecules (e.g., relaxed, or supercoiled) with various sizes can be synthesized. Unwanted DNA molecules, e.g., unligated oligomers, can be removed by exonucleases, such as T5 exonuclease, T7 exonuclease, lambda exonuclease, E. coli exonuclease I and/or III. A method of converting the single-stranded circular DNA molecules into double-stranded circular DNA molecules is also described. The single-stranded and double-stranded circular DNA molecules can be used in a variety of applications.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for synthesizing circular double-stranded DNA molecules, the method consisting of: providing a DNA template comprising two sequence-specific recombination sites; performing PCR to produce linear double-stranded DNA fragments comprising the two sequence-specific recombination sites; converting the linear double-stranded DNA fragments to relaxed circular double-stranded DNA molecules via a recombination reaction in the presence of a recombinase; removing unreacted linear double-stranded DNA fragments by adding an exonuclease; and optionally, converting the relaxed circular double-stranded DNA molecules to supercoiled double-stranded DNA molecules. 2. The method of claim 1 , wherein the two sequence-specific recombination sites are selected from loxP sites, flippase recognition target (FRT) sites and a combination thereof. 3. The method of claim 1 , wherein the PCR is performed in the presence of a DNA polymerase, dNTPs and primers selected from sequences comprising SEQ ID NO: 1 or 2. 4. The method of claim 1 , wherein the recombinase is Cre recombinase. 5. The method of claim 1 , wherein the exonuclease is T5 exonuclease. 6. The method of claim 1 , wherein converting the relaxed circular double-stranded DNA molecules to supercoiled double-stranded DNA molecules comprises adding a DNA topoisomerase selected from DNA gyrase or DNA topoisomerase I. 7. The method of claim 1 , wherein the DNA template is a circular DNA template.

Assignees

Inventors

Classifications

  • C12Q1/6846Primary

    Common amplification features · CPC title

  • Nucleic acid amplification reactions · CPC title

  • C12P19/34Primary

    Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12371725B2 cover?
A method, which synthesizes closed circular single-stranded and double-stranded DNA molecules using in vitro enzymatic systems, is described. Circular single-stranded DNA molecules and double-stranded DNA molecules (e.g., relaxed, or supercoiled) with various sizes can be synthesized. Unwanted DNA molecules, e.g., unligated oligomers, can be removed by exonucleases, such as T5 exonuclease, T7 e…
Who is the assignee on this patent?
Leng Fenfei, The Florida International Univ Board Of Trustees
What technology area does this patent fall under?
Primary CPC classification C12Q1/6846. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).